May 9
|
Orthofix Announces FDA 510(k) Clearance for the Rodeo Telescopic Nail
|
May 8
|
Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2024 Earnings Call Transcript
|
May 8
|
Orthofix Medical Inc (OFIX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
|
May 8
|
Q1 2024 Orthofix Medical Inc Earnings Call
|
May 7
|
Orthofix Medical Inc. (OFIX) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Net Loss Widening
|
May 7
|
Orthofix Reports First Quarter 2024 Results
|
Apr 26
|
Marriott Vacations, Carrols Restaurant Group, and More Stocks See Action From Activist Investors
|
Apr 23
|
Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
|
Apr 16
|
Orthofix Names Andres Cedron as New Chief Legal Officer
|
Mar 18
|
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
|
Mar 12
|
Orthofix (OFIX) Q4 Earnings Beat Estimates, Gross Margin Up
|
Mar 7
|
Orthofix Medical Inc (OFIX) Reports Significant Sales Growth and Improved EBITDA in Q4 and Full ...
|
Mar 7
|
Orthofix Medical Inc. (NASDAQ:OFIX) Q4 2023 Earnings Call Transcript
|
Mar 6
|
Q4 2023 Orthofix Medical Inc Earnings Call
|
Mar 5
|
Orthofix Reports Fourth Quarter and Full Year 2023 Results
|
Jan 16
|
Julie Andrews Begins as New Chief Financial Officer at Orthofix
|
Jan 9
|
Orthofix Medical Inc. Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
|
Jan 8
|
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
|
Dec 27
|
Orthofix (OFIX) Releases New Data for Spinal Fusion Procedures
|
Dec 21
|
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis
|